• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

指南指导的药物治疗对营养不良的体弱老年射血分数降低的急性心力衰竭患者的有效性。

Effectiveness of Guideline-Directed Medical Therapy for Acute Heart Failure With Reduced Ejection Fraction in Frail Elderly Patients With Malnutrition.

作者信息

Takaoka Yoshimitsu, Rahman Mahbubur, Asano Taku, Kijima Yasufumi, Aoki Jiro

机构信息

Department of Cardiovascular Medicine, St. Luke's International Hospital Tokyo Japan.

Division of Epidemiology, Graduate School of Public Health, St. Luke's International University Tokyo Japan.

出版信息

Circ Rep. 2025 Feb 28;7(4):267-274. doi: 10.1253/circrep.CR-25-0003. eCollection 2025 Apr 10.

DOI:10.1253/circrep.CR-25-0003
PMID:40213803
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11981668/
Abstract

BACKGROUND

The appropriateness of guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) in malnourished elderly patients is unclear. This study aims to assess the effects of GDMT on acute heart failure (AHF) with reduced ejection fraction in this specific population using the Geriatric Nutritional Risk Index (GNRI).

METHODS AND RESULTS

We retrospectively collected data of patients aged >75 years who were admitted to St. Luke's International Hospital for AHF with reduced ejection fraction from 2011 to 2022. Malnutrition was defined as a GNRI score <92. GDMT was defined as the prescription of 3 or more of the medications for HFrEF at the time of discharge. Among 467 patients, 345 (73.9%) had malnutrition. In the low GNRI group, GDMT was associated with a lower all-cause mortality at 1 year (HR 0.46; 95% CI 0.24-0.89; P=0.021), but not in heart failure (HF) readmission (HR 0.83; 95% CI 0.55-1.25; P=0.364) at 1 year after discharge. In the high GNRI group, GDMT was not significantly associated with these outcomes (all-cause mortality: HR 0.59; 95% CI 0.12-3.06; P=0.534; HF readmission: HR 0.55; 95% CI 0.29-1.05; P=0.069).

CONCLUSIONS

Implementation of GDMT in AHF with reduced ejection fraction may enhance prognosis, even among elderly patients with malnutrition.

摘要

背景

对于营养不良的老年射血分数降低的心力衰竭(HFrEF)患者,指南指导的药物治疗(GDMT)是否合适尚不清楚。本研究旨在使用老年营养风险指数(GNRI)评估GDMT对这一特定人群中射血分数降低的急性心力衰竭(AHF)的影响。

方法与结果

我们回顾性收集了2011年至2022年因射血分数降低的AHF入住圣卢克国际医院的75岁以上患者的数据。营养不良定义为GNRI评分<92。GDMT定义为出院时开具3种或更多治疗HFrEF的药物处方。在467例患者中,345例(73.9%)存在营养不良。在低GNRI组中,GDMT与1年时较低的心衰全因死亡率相关(HR 0.46;95%CI 0.24-0.89;P=0.021),但与出院后1年的心衰(HF)再入院率无关(HR 0.83;95%CI 0.55-1.25;P=0.364)。在高GNRI组中,GDMT与这些结局无显著相关性(全因死亡率:HR 0.59;95%CI 0.12-3.06;P=0.534;HF再入院率:HR 0.55;95%CI 0.29-1.05;P=0.069)。

结论

在射血分数降低的AHF中实施GDMT可能改善预后,即使在营养不良的老年患者中也是如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1562/11981668/e8dd1b85ed40/circrep-7-267-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1562/11981668/4802337e5e59/circrep-7-267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1562/11981668/dee50171cb2d/circrep-7-267-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1562/11981668/e8dd1b85ed40/circrep-7-267-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1562/11981668/4802337e5e59/circrep-7-267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1562/11981668/dee50171cb2d/circrep-7-267-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1562/11981668/e8dd1b85ed40/circrep-7-267-g003.jpg

相似文献

1
Effectiveness of Guideline-Directed Medical Therapy for Acute Heart Failure With Reduced Ejection Fraction in Frail Elderly Patients With Malnutrition.指南指导的药物治疗对营养不良的体弱老年射血分数降低的急性心力衰竭患者的有效性。
Circ Rep. 2025 Feb 28;7(4):267-274. doi: 10.1253/circrep.CR-25-0003. eCollection 2025 Apr 10.
2
Guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction: a cohort study.指导下的医学治疗在老年射血分数降低心力衰竭患者中的应用:一项队列研究。
BMJ Open. 2020 Feb 6;10(2):e030514. doi: 10.1136/bmjopen-2019-030514.
3
Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.肺动脉压指导心力衰竭伴射血分数降低患者的管理。
J Am Coll Cardiol. 2017 Oct 10;70(15):1875-1886. doi: 10.1016/j.jacc.2017.08.010.
4
Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.出院前优化指南指导的药物治疗对射血分数降低的心力衰竭住院患者死亡率和心力衰竭再入院的影响。
Am J Cardiol. 2018 Apr 15;121(8):969-974. doi: 10.1016/j.amjcard.2018.01.006. Epub 2018 Feb 21.
5
Impact of Malnutrition in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial.营养不良对心力衰竭合并二尖瓣反流患者的影响:COAPT 试验。
J Am Coll Cardiol. 2023 Jul 11;82(2):128-138. doi: 10.1016/j.jacc.2023.04.047. Epub 2023 Jun 9.
6
Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction.医学治疗对射血分数降低的心力衰竭患者的预后意义。
ESC Heart Fail. 2023 Dec;10(6):3677-3689. doi: 10.1002/ehf2.14559. Epub 2023 Oct 7.
7
A scoring evaluation for the practical introduction of guideline-directed medical therapy in heart failure patients.用于心力衰竭患者指南导向的医学治疗实际引入的评分评估。
ESC Heart Fail. 2023 Dec;10(6):3352-3363. doi: 10.1002/ehf2.14524. Epub 2023 Sep 6.
8
Hospital Heart Failure Medical Therapy Score and Associated Clinical Outcomes and Costs.医院心力衰竭药物治疗评分及其相关临床结局和成本。
JAMA Cardiol. 2024 Nov 1;9(11):1029-1038. doi: 10.1001/jamacardio.2024.2969.
9
Frailty interferes with the guideline-directed medical therapy in heart failure patients with reduced ejection fraction.衰弱会干扰射血分数降低的心力衰竭患者的指南指导的医学治疗。
ESC Heart Fail. 2023 Feb;10(1):223-233. doi: 10.1002/ehf2.14163. Epub 2022 Oct 3.
10
Virtual optimization of guideline-directed medical therapy in hospitalized patients with heart failure with reduced ejection fraction: the IMPLEMENT-HF pilot study.住院射血分数降低的心力衰竭患者指南指导的医学治疗的虚拟优化:IMPLEMENT-HF 初步研究。
Eur J Heart Fail. 2021 Jul;23(7):1191-1201. doi: 10.1002/ejhf.2163. Epub 2021 Apr 13.

本文引用的文献

1
Characteristics, Treatment, and Prognosis in Octogenarian and Older Patients With Acute Heart Failure in Japan - Prospective Observational Study on Acute Pharmacotherapy and Prognosis in Management of Acute Heart Failure (POPEYE-AHF Registry).日本老年及高龄急性心力衰竭患者的特征、治疗与预后——急性心力衰竭管理中急性药物治疗与预后的前瞻性观察研究(大力水手-AHF注册研究)
Circ J. 2024 Dec 25;89(1):83-92. doi: 10.1253/circj.CJ-24-0299. Epub 2024 Sep 6.
2
Multifactorial risk factors for hospital readmissions among patients with symptoms of advanced heart failure.患有晚期心力衰竭症状的患者再次住院的多因素危险因素。
ESC Heart Fail. 2024 Apr;11(2):1144-1152. doi: 10.1002/ehf2.14670. Epub 2024 Jan 25.
3
Prognostic Impact of Hyperpolypharmacy Due to Noncardiovascular Medications in Patients After Acute Decompensated Heart Failure - Insights From the Clue of Risk Stratification in the Elderly Patients With Heart Failure (CURE-HF) Registry.
急性失代偿性心力衰竭患者因非心血管药物引起的多重用药对预后的影响——来自心力衰竭老年患者危险分层线索(CURE-HF)登记的见解。
Circ J. 2023 Dec 25;88(1):33-42. doi: 10.1253/circj.CJ-22-0712. Epub 2023 Aug 4.
4
Physical Frailty and Use of Guideline-Recommended Drugs in Patients With Heart Failure and Reduced Ejection Fraction.身体虚弱与射血分数降低的心力衰竭患者使用指南推荐药物。
J Am Heart Assoc. 2023 Jun 20;12(12):e026844. doi: 10.1161/JAHA.122.026844. Epub 2023 Jun 10.
5
Real-world safety of neurohormonal antagonist initiation among older adults following a heart failure hospitalization.心力衰竭住院后老年患者使用神经激素拮抗剂的真实世界安全性。
ESC Heart Fail. 2023 Jun;10(3):1623-1634. doi: 10.1002/ehf2.14317. Epub 2023 Feb 20.
6
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial.升阶梯治疗急性心力衰竭指南导向的药物治疗的安全性、耐受性和疗效(STRONG-HF):一项多中心、开放标签、随机试验。
Lancet. 2022 Dec 3;400(10367):1938-1952. doi: 10.1016/S0140-6736(22)02076-1. Epub 2022 Nov 7.
7
Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial.电子提醒改善门诊心力衰竭治疗:一项集群随机试验。
J Am Coll Cardiol. 2022 Jun 7;79(22):2203-2213. doi: 10.1016/j.jacc.2022.03.338. Epub 2022 Apr 3.
8
Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata.基于证据的治疗在射血分数降低的心力衰竭各年龄段患者中的应用。
Eur J Heart Fail. 2022 Jun;24(6):1047-1062. doi: 10.1002/ejhf.2483. Epub 2022 Apr 3.
9
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
10
Differential effect of malnutrition between patients hospitalized with new-onset heart failure and worsening of chronic heart failure.新发心力衰竭住院患者与慢性心力衰竭恶化患者之间营养不良的差异效应。
ESC Heart Fail. 2021 Jun;8(3):1819-1826. doi: 10.1002/ehf2.13279. Epub 2021 Mar 2.